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Gabriel Kollárovič, Caitrı́ona E. Topping, Edward P. Shaw and Anna L. Chambers *
DNA-protein Interactions Unit, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK
Received May 21, 2019; Revised November 18, 2019; Editorial Decision November 21, 2019; Accepted November 22, 2019
ABSTRACT
Efficient double-strand break repair in eukaryotes
requires manipulation of chromatin structure. ATP-
dependent chromatin remodelling enzymes facili-
tate different DNA repair pathways, during different
stages of the cell cycle and in varied chromatin en-
vironments. The contribution of remodelling factors
to double-strand break repair within heterochromatin
during G2 is unclear. The human HELLS protein is a
Snf2-like chromatin remodeller family member and
is mutated or misregulated in several cancers and
some cases of ICF syndrome. HELLS has been im-
plicated in the DNA damage response, but its mech-
anistic function in repair is not well understood.
We discover that HELLS facilitates homologous re-
combination at two-ended breaks and contributes
to repair within heterochromatic regions during G2.
HELLS promotes initiation of HR by facilitating end-
resection and accumulation of CtIP at IR-induced
foci. We identify an interaction between HELLS and
CtIP and establish that the ATPase domain of HELLS
is required to promote DSB repair. This function of
HELLS in maintenance of genome stability is likely
to contribute to its role in cancer biology and demon-
strates that different chromatin remodelling activities
are required for efficient repair in specific genomic
contexts.
INTRODUCTION
Unrepaired double-strand breaks (DSBs) can lead to cyto-
toxicity, whilst misrepair of breaks can result in genomic
instability that may promote tumourigenesis (1). There are
two major pathways of DSB repair (DSBR)-canonical non-
homologous end joining (c-NHEJ) and homologous recom-
bination (HR). HR requires a sister chromatid to provide a
template for repair and therefore is restricted to the S and
G2 phases of the cell cycle (2). HR occurs with slower ki-
netics than NHEJ and is error-free. HR performs an es-
sential function in repair of one-ended breaks generated by
collapse of replication forks during S-phase, as well as con-
tributing to repair of two-ended breaks in G2 (3,4). HR be-
gins with break recognition and initiation of end-resection
by the MRE11-RAD50-NBS1 (MRN) complex in associa-
tion with CtIP (5–7). Further extensive resection by EXO1
or BLM/DNA2 (8,9) results in 3′ single-stranded DNA (ss-
DNA) overhangs that are initially coated in RPA (Repli-
cation Protein A). BRCA2 promotes replacement of RPA
with RAD51, to produce a RAD51 nucleofilament that me-
diates homology searching and strand invasion.
In eukaryotes, DSBR occurs in a chromatin environ-
ment, which can act as a barrier to repair. Transcriptionally
repressed and repetitive regions of the genome are pack-
aged into compact, condensed heterochromatin (10). Re-
pair of DSBs within heterochromatin occurs more slowly
than breaks located in euchromatin during both G0/G1
and G2 (11,12) and the mutation rate is higher within het-
erochromatin, in part due to its repetitive nature (13). In
G1, heterochromatic breaks are repaired by NHEJ and it is
proposed that during G2 they are repaired by HR (4,14,15).
In both instances, heterochromatin repair correlates with a
slow component of repair (∼15% of DSBs). The DNA dam-
age response kinase, ATM has been shown to play a role in
overcoming the barrier to repair posed by heterochromatin
in both G0/G1 cells and G2 (4,11).
ATP-dependent chromatin remodelling enzymes, couple
ATP hydrolysis to translocation along DNA to alter nucleo-
some composition or position (16). Chromatin remodelling
is necessary for efficient DSBR (17). INO80, SWR1, ISW1
and SWI/SNF complexes are recruited to DSBs and pro-
mote repair, whilst CHD1, SRCAP and SMARCAD1 have
been associated with end-resection (reviewed in (17)). Ques-
tions remain over whether each remodeller is required at
every break to enable different stages of repair, or if spe-
cific remodellers facilitate repair of subsets of breaks, for in-
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stance those with greater damage complexity or within dif-
ferent chromatin contexts. During G0/G1, efficient repair
within heterochromatin requires dispersal of CHD3 (18)
and activity of the ACF1-SNF2H/SMARCA5 chromatin
remodelling complex (19). However, involvement of ATP-
dependent chromatin remodelling in repair of heterochro-
matic breaks during G2, is poorly understood.
Sequence analysis identifies the human HELLS protein
(also known as LSH, PASG or SMARCA6) as a Snf2-like
chromatin remodelling enzyme (20–23). HELLS ATPase
is stimulated by nucleosomes and remodelling activity has
been demonstrated for a HELLS-CDC7a complex, with the
Drosophila homolog, DDM1, also shown to slide nucleo-
somes in vitro (24–26). HELLS is ubiquitously expressed,
with highest levels found in proliferating tissues active in re-
combination such as the thymus and testes (21–23). HELLS
is mutated or misregulated in tumour samples from several
cancer types (27–31) and is also mutated in some cases of
immunodeficiency-centromeric instability-facial anomalies
syndrome (ICF), characterized by instability within peri-
centromeric repeats (32). HELLS-deficient mice either age
prematurely or die shortly after birth, while HELLS mutant
MEFs (mouse embryonic fibroblasts) display premature on-
set of senescence, reduced proliferation, aberrant chromo-
some segregation and increased DNA content (27,33,34).
HELLS-deficient MEFs have reduced global DNA methy-
lation and it has been proposed that HELLS permits re-
cruitment of DNA methyltransferases for de novo DNA
methylation, particularly at repetitive sequences (27,35–38).
Budding yeast don’t methylate their DNA, but possess a
HELLS homolog (Irc5), raising the possibility of another
conserved function for this subfamily of chromatin remod-
elling enzymes (39,40). Indeed, a role for HELLS in main-
tenance of genome stability has emerged. HELLS-deficient
MEFs and MRC5 human fibroblasts display sensitivity
to DNA damaging agents, inefficient repair and aberrant
DNA damage responses (24). However, the mechanistic role
of HELLS in protection of genome integrity is not yet fully
described. Two unanswered key questions are: in which con-
texts or genomic regions does HELLS contribute to repair,
and which step of DNA repair is impacted by HELLS?
In this study, we find that the human HELLS protein pro-
motes genome stability following IR and as part of the re-
sponse to spontaneously occurring damage. We find that
HELLS facilitates DSBR by HR during G2 and is required
for efficient repair of breaks within heterochromatin. Our
data show that HELLS impacts DNA end-resection and
promotes accumulation of CtIP in IR-induced foci. We un-
cover an interaction between HELLS and CtIP and estab-
lish that HELLS ATPase activity contributes to its function
in DSBR. Our data reveal a role for the HELLS chromatin
remodeller in repair of heterochromatic DSBs in G2 and
provide insights into the function of HELLS in preventing
genome instability.
MATERIALS AND METHODS
Cell culture and irradiation
1BR-hTERT human fibroblasts (provided by Prof. P.
Jeggo), U2OS and HeLa cells were cultured in Dulbecco’s
modified Eagle’s medium (D-MEM) GlutaMAX™ (Gibco)
supplemented with 10% foetal bovine serum (FBS)(Gibco),
100 units/ml penicillin, and 100 g/ml streptomycin
(Gibco). Cells were grown at 37◦C, 95% humidity, 5% CO2.
Cells were irradiated 24 h after siRNA knock-down, with a
Cs137 source RX30/55M Irradiator (Gravatom Industries
Ltd).
For G2 analyses, 3 g/ml aphidicolin (Sigma-Aldrich)
was added prior to IR, to prevent progression of S-phase
cells into G2. Where indicated, 10 M ATM inhibitor (Ku-
55933) was added 1 h prior to IR or 40 g/ml chloroquine
(Sigma-Aldrich) 2 h prior to irradiation. For experiments
involving DRB, either DMSO or 100 M DRB was added
1 h prior to irradiation.
siRNA knock-downs, plasmids and transfection
siRNA oligonucleotides were transfected using Lipofec-
tamine RNAiMAX reagent (Invitrogen). 5 nM siRNA du-
plexes were used for reverse transfection of 5 × 105 log-
arithmically growing cells in a six-well plate. siRNA se-
quences are provided in the appendix. For complementa-
tion experiments, knock-down was performed using a sin-
gle HELLS siRNA oligonucleotide 24 h prior to transfec-
tion of pMyc-HELLS plasmid DNA using Lipofectamine
3000 (Invitrogen). Media was changed 6 h after plasmid
transfection and cells incubated for 24 h prior to irradi-
ation. pMyc-HELLS expresses N-terminally Myc-tagged
siRNA-resistant HELLS from a CMV promoter. It was
constructed by introducing a myc-epitope and MCS down-
stream of the CMV promoter of pUHD15-1 (lacking the
tTA), to create pALC43 (sequence available on request).
HELLS cDNA (from NM 18063.3 in pReceiver-M98 from
Tebu) into which mutations that confer resistance to si-
HELLS were introduced (ATAGGGAGAGCACAG) was
then cloned into the NotI-SalI sites of pALC43 to create
pMyc-HELLS.
Cell extracts
For whole cell extracts, cells were lysed into RIPA buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 10
mM K2HPO4, 10% (v/v) glycerol, 1% (v/v) Triton X-100,
0.05% SDS, 1 mM DTT, protease inhibitors (Roche) and
debris removed prior to loading. For nuclear extracts, cells
were resuspended in hypotonic buffer (100 mM HEPES pH
7.9, 10 mM KCl, 1 mM MgCl2, 1 mM DTT, 1% TritonX-
100 and protease inhibitors (Roche)) and sheared following
addition of 0.5% NP-40. Nuclei were pelleted by centrifuga-
tion at 3 000 rpm for 5 min at 4◦C and were resuspended in
hypotonic buffer containing 1 U/l of benzonase (Merck).
Extracts were incubated on ice for 30 min, before addition
of 400 mM NaCl and incubation for a further 1 h at 4◦C,
prior to centrifugation at 13 000 rpm for 15 min at 4◦C and
using the supernatant for analysis. For chromatin extracts,
nuclei were harvested as above and the nuclear pellet resus-
pended in 100 l extraction buffer (3 mM EDTA, 0.2 mM
EGTA and protease inhibitors (Roche)). Samples were spun
at 13 000 rpm for 5 min at 4◦C and the chromatin pellet re-
suspended in 20 l 0.2 M HCl before neutralization with 80
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Immunofluorescence and colocalization analysis
Cells grown on glass coverslips were pre-extracted with
0.2% Triton-X 100 in PBS for 1 min, before fixation with
4% (w/v) paraformaldehyde for 10 min at room tempera-
ture (RT). Cells were washed with PBS and incubated with
primary antibody diluted in 2% (w/v) bovine serum albu-
min (BSA) in PBS for 1 h at RT. After washing with PBS,
cells were incubated with secondary antibody diluted in 2%
BSA for 1 h at RT, followed by 10 min at RT in 100 ng/l
DAPI. After washing in PBS, coverslips were mounted with
Vectashield (Vector Laboratories). Antibodies used are pro-
vided in the appendix.
For BrdU foci analysis of resection, cells were incubated
with 10 g/ml BrdU for 16 h and irradiated with 10 Gy IR.
1 h later, cells were washed with PBS and incubated in 1 ml
extraction buffer 1 (10 mM PIPES pH 7, 100 mM NaCl,
300 mM Sucrose, 3 mM MgCl2, 1 mM EGTA, 0.5% Triton-
X 100) for 10 min on ice. After washing with PBS, cells
were incubated with 1 ml extraction buffer 2 (10 mM Tris–
HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2, 1% Tween 20,
0.5% sodium deoxycholate) for 10 min on ice. After another
wash, cells were fixed with paraformaldehyde (4%, w/v) for
20 min on ice, washed in PBS and permeabilized with 0.5%
Triton-X 100 in PBS for 10 min on ice. After washing, cells
were incubated with 0.5 ml 5% BSA (w/v) in PBS for 20 min
on ice and then were incubated overnight with primary an-
tibody for 16 h at 4◦C and secondary antibody as described
above.
For colocalization studies, cells were fixed with ice-cold
methanol for 20 min. Dried slides were washed with PBS
and primary and secondary antibody staining was per-
formed as described above. CellProfiler was used to quan-
tify colocalization by measuring the fraction of  -H2AX
positive pixels that overlap with HELLS-positive pixels.
All images were taken using either Leica DMI600 mi-
croscope, with Leica DFC365FX monochrome CCD cam-
era, 40× lenses (serial number 506201), acquisition soft-
ware Leica LAS-X, or using Leica DMR, with R6 Retiga
camera (QImaging) and CoolLED pE-300 light source,
40× lenses (serial number 506144), acquisition software:
Micro-Manager.
HR reporter assay
siRNA oligonucleotides were transfected into U2OS-DR-
GFP cells (kindly provided by Maria Jasin). 24 h later cells
were transfected with pCBAS plasmid (expressing I-SceI)
and after a further 48 h, cells were harvested. Cells were
washed with PBS and analysed for GFP fluorescence by
FACS as described in the appendix.
Clonogenic survival assay
48 h after siRNA transfection, 500 cells were seeded into
6 cm dishes and olaparib (Ku-0059436, Stratech) added
at indicated concentrations. Cells were fixed with ice-cold
methanol after 14 days and stained with 1% (w/v) crystal
violet.
Sister chromatid exchange assays
HeLa cells transfected with siRNA oligonucleotides were
incubated with 10 M BrdU for 48 h. To enrich for mitotic
cells, 1 mM caffeine and 0.2 g/ml colcemid were added 8
h after irradiation with 3 Gy and cells were harvested af-
ter a further 4 h. For chromosome spreads, cells were resus-
pended in 75 mM KCl for 16 min at 37◦C, before centrifu-
gation at 1 500 rpm for 10 min at 4◦C. Cells were fixed in
3:1 methanol: glacial acetic acid and metaphases dropped
onto slides. Chromosome spreads were airdried, incubated
with 10 g/ml Hoechst, washed with Sorensen buffer pH
6.8, covered with Sorensen buffer and a cover slip and ir-
radiated under 365 nm UV lamp for 1 h. Coverslips were
removed and slides incubated in SSC buffer (2 M NaCl, 0.3
M Na-citrate pH 7) at 67◦C for 1 h before staining with 10%
Giemsa (Acros) in Sorensen buffer for 30 min at RT. Slides
were washed with water and dried overnight before mount-
ing.
Co-immunoprecipitation
U2OS cells transfected with the indicated plasmids were ir-
radiated, where shown, with 3 Gy IR 1 h prior to being
harvested. Cells were lysed and nuclear extracts prepared
as above, with the exception that NaCl was adjusted to 200
mM. Extracts were incubated for 2 h with 4 g -myc or
IgG before addition of Protein A Dynabeads and a further
1 h incubation at 4◦C. 3 × 1 ml washes in lysis buffer +
200 mM NaCl were performed and bound protein eluted
by boiling prior to analysis by western blotting.
In vitro pull-down assay
Details of purification of recombinant His-HELLS and
CtIP proteins are provided in the appendix. His-select
Cobalt affinity beads (Sigma) were equilibrated in binding
buffer (40 mM HEPES pH 7.5, 30 mM imidazole pH 8.0,
150 mM NaCl, 0.1% Tween, 10% glycerol, 0.2% BSA) and
100 ng His-HELLS protein bound for 1 h at 4◦C. 100 ng re-
combinant CtIP protein was added and reactions were in-
cubated for 1 h at 4◦C. Alternatively 2 g His-HELLS and
0.6 g CtIP were mixed and incubated for 30 min at 4◦C
before capture using 1 l anti-His antibody and protein A
Dynabeads for 40 min at 4◦C. Beads were washed in equili-
bration buffer and bound protein eluted by boiling in SDS-
PAGE sample buffer for analysis by western blotting.
RESULTS
HELLS promotes genome stability
To investigate the function of the human HELLS protein in
maintenance of genome stability, we established conditions
to deplete HELLS using siRNA in hTert-immortalized
normal human fibroblasts (1BR-hTert) (Figure 1A). Phos-
phorylated histone H2AX foci ( -H2AX), a marker of
DSBs, were visualized in G2 cells identified by their pan-
nuclear CENP-F staining (41) (Figure 1B). Unexpectedly,
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Figure 1. HELLS promotes genome stability in undamaged cells and fol-
lowing IR. (A) Western blot analysis of efficiency of HELLS depletion
by siRNA in 1BR-hTert cells. Anti-tubulin was used as a loading con-
trol. (B) Representative immunofluorescent images of spontaneously aris-
ing  -H2AX foci in 1BR-hTert cells transfected with the indicated siRNA.
CENPF staining was used to identify G2 cells. (C) Quantification of spon-
taneous  -H2AX foci in G2 nuclei of 1BR-hTert cells transfected with in-
dicated siRNA. Data are from six independent experiments. (D) Quan-
tification of micronuclei in undamaged 1BR-hTert cells transfected with
indicated siRNA. A minimum of 1100 nuclei were analysed, from three
independent experiments. (E) Representative immunofluorescent images
treated with the indicated siRNA at different time points after exposure to
3 Gy IR. (F) Quantification of clearance of  -H2AX foci following 3 Gy
irradiation in 1BR-hTert cells treated with indicated siRNA. Data from
three independent experiments. (G) Quantification of micronuclei in 1BR-
hTert cells transfected with indicated siRNA after 6 Gy IR. A minimum of
715 nuclei were analysed, from three independent experiments. (H) siRNA-
resistant WT or K254R mutant constructs were introduced to siHELLS
cells and  -H2AX foci numbers quantified 24 h following 3 Gy IR. Data
from a minimum of three independent experiments. Data shown in panels
C, F and H are mean + SEM. **** indicates a P-value of <0.0001, and ns
indicates not significant by unpaired two-tailed t-test analysis.
foci in undamaged, asynchronously growing G2 cells (Fig-
ure 1C and Supplementary Figure S1A). An increase in
spontaneous  -H2AX foci did not occur in serum-starved
cells downregulated for HELLS (Supplementary Figure
S1B). HELLS-depleted fibroblasts did not show significant
changes in cell cycle profile and retained functional G1/S
and G2/M checkpoints (Supplementary Figure S1C). The
greater number of  -H2AX foci is consistent with either in-
creased spontaneous break formation, or a defect in repair
of DSBs on HELLS downregulation.
The incidence of spontaneous micronuclei was also ele-
vated in cells downregulated for HELLS (Figure 1D). Mi-
cronuclei result when a chromosome or chromosome frag-
ment is not incorporated into the daughter nuclei during mi-
tosis and can arise due to chromosome segregation defects
or the presence of unrepaired or misrepaired breaks. Our
data from HELLS-depleted fibroblasts are consistent with
observations in LSH –/– MEFs (the murine homologue of
HELLS) which showed elevated micronuclei formation and
chromosomal instability (34). These data support a func-
tion for the human HELLS protein in protection of genome
integrity.
HELLS depletion results in genome instability following ex-
posure to IR
To examine the role of HELLS in DSBR, cells were irra-
diated with 3 Gy IR and numbers of  -H2AX foci in G2
cells analysed over time (Figure 1E). Addition of aphidi-
colin at the time of irradiation precluded cells damaged
during G1 progressing into G2 and prevented one-ended
breaks arising during S-phase from entering our analysis
(4,14). Aphidicolin has been shown to not affect NHEJ,
HR or numbers of  -H2AX foci (4,42) and the cell cycle
profile of HELLS-depleted cells 24 h after aphidicolin, ir-
radiation or both, was the same as control cells (Supple-
mentary Figure S1D). S-phase cells were excluded based on
their pan-nuclear, aphidicolin-dependent H2AX phospho-
rylation and CENPF-positive staining. Consequently, we
are examining the effect of HELLS on repair of two-ended
DSBs that are generated and repaired during G2. HELLS
downregulated cells possessed comparable numbers of  -
H2AX foci to cells treated with control siRNA 2 h after ir-
radiation, but at later times after IR (6 and 24 h) HELLS-
depleted cells displayed increased numbers of persistent  -
H2AX foci (Figure 1F and Supplementary Figure S1E).
These data suggest that break formation by IR and rapid
DSBR is independent of HELLS, but that HELLS deple-
tion results in a defect in the slower component of repair in
G2 cells. This phenotype is reminiscent of the late DSBR
in cells deficient in ATM, Artemis, RAD51 or BRCA2 (4).
HELLS localizes to the nuclear fraction and levels did not
increase following IR (Supplementary Figure S1F). Con-
sistent with a function for HELLS in repair of DSBs, irra-
diated HELLS-deficient cells also exhibited increased fre-
quency of micronuclei compared with control cells (Fig-
ure 1G). Together these data suggest a role for the human
HELLS protein in promoting timely DSB repair and main-







niversity of Bristol Library user on 08 January 2020
Nucleic Acids Research, 2019 5
The ATP-binding site of HELLS is necessary for its function
in DSBR in G2
To confirm the role of HELLS in  -H2AX clearance and
eliminate the possibility of off-target effects, an siRNA-
resistant myc-tagged version of HELLS was reintroduced to
HELLS-depleted cells (Figure 1H, Supplementary Figure
S1G and H). U2OS cells transfected with siHELLS and an
empty vector displayed persistence of  -H2AX foci in G2
cells following irradiation relative to cells transfected with
control siRNA. In contrast, cells transfected with siHELLS
but expressing ectopic siRNA-resistant myc-HELLS did
not display elevated numbers of  -H2AX foci. This con-
firms that HELLS contributes to efficient repair of IR-
induced DSBs in G2.
Disruption of helicase motif I (Walker A box) dis-
rupts ATP binding and remodelling activity in other ATP-
dependent chromatin remodelling enzymes (43,44). Intro-
duction of an siRNA-resistant version of HELLS contain-
ing a substitution in motif I (K254R) failed to restore the
number of  -H2AX foci after 24 h to the levels observed
in cells transfected with either control siRNA or siHELLS
complemented with wt HELLS (Figure 1H and Supple-
mentary Figure S1G). The mutant HELLS protein was ex-
pressed at similar levels to the wt protein (Supplementary
Figure S1H); the ability of HELLS to bind ATP and likely
remodel chromatin is required for its role in promoting DSB
repair.
HELLS depletion results in defects in the homologous recom-
bination pathway of DSBR
We find that unirradiated HELLS-depleted cells possess el-
evated numbers of  -H2AX foci. Spontaneously occurring
breaks are predominantly the result of collapsed replica-
tion forks that are primarily repaired by the HR pathway
either during S-phase or G2. In addition, slow-clearing IR-
induced  -H2AX foci in G2 have been associated with HR
(4). Furthermore, HELLS expression is highest in CENPF-
positive cells (S/G2) when HR is functional, (Figure 2A and
Supplementary Figure S2A, antibody specificity confirmed
by knock-down in Supplementary Figure S2B) and in pro-
liferating tissues active in recombination (21,23). Taken to-
gether, this led us to examine whether HELLS participates
in the HR pathway of DSBR.
During G2, the HR-specific RAD51 protein accumu-
lates at IR-induced foci (Figure 2B). Compared with control
cells, we observed fewer RAD51 foci 2 hours after IR and
a reduction in the percentage of G2 nuclei with more than
20 RAD51 foci in 1BR-hTert cells depleted of HELLS (Fig-
ure 2C, Supplementary Figure S2C and S2D). This defect in
RAD51 foci formation was confirmed in a second cell line,
U2OS (Figure 2D, Supplementary Figure S2E, F and G). In
both cell lines, a significant difference was no longer present
6 h after irradiation, when RAD51 foci in control cells have
begun to disperse as repair proceeds. These data demon-
strate that HELLS facilitates the homologous recombina-
tion pathway of DSB repair.
To examine whether the defect in RAD51 accumulation
at sites of damage translates to an impact on HR activity,
we examined sister chromatid exchange (SCE) events and
sensitivity to PARP inhibition. SCEs are the result of HR
activity and can be induced by IR. Metaphase spreads from
HeLa cells depleted of HELLS showed fewer IR-induced
SCEs than control cells, but no change in the frequency of
spontaneous SCEs (Figure 2E). Again, this is reminiscent
of downregulation of ATM or Artemis, which does not af-
fect levels of spontaneous SCEs, but decreases the frequency
of SCEs after irradiation (4). Another well-documented
property of cells with an HR defect is their sensitivity to
PARP inhibitors (PARPi) (45–47). As established, deple-
tion of the BRCA1 HR protein results in sensitivity to the
PARPi, olaparib (Figure 2F). Cells depleted of HELLS also
displayed reduced survival on exposure to olaparib, rela-
tive to cells transfected with control siRNA (Figure 2F).
HELLS-deficient cells were less sensitive to PARPi than
BRCA1-deficient cells, suggesting that HELLS does not act
as an essential, core HR factor. Co-depletion of BRCA1
and HELLS resulted in a survival frequency comparable
to BRCA1 depletion alone, suggesting an epistatic relation-
ship between HELLS and BRCA1. Taken together, these
data suggest that HELLS promotes HR activity.
The murine homologue of HELLS, LSH, has been best-
studied for its role in de novo methylation of repetitive DNA
during development (38,48–50). LSH was found to inter-
act with DNA methyltransferase DNMT3b and indirectly
associate with the maintenance DNA methyltransferase,
DNMT1 (36). We did not observe a defect in IR-induced
RAD51 foci accumulation in cells depleted for DNMT3b or
the DNMT1 (Supplementary Figure S2H-K). Knock-down
of DNMT3b and DNMT1 were confirmed by western blot
analysis and did not reduce HELLS expression (Supple-
mentary Figure S2L and S2M). Furthermore, knock-down
of HELLS does not result in decreased levels of 5-methyl cy-
tosine in MRC5 cells or MEFs within the timescale of our
analysis (24,51,52). As such, the function of HELLS in HR
appears independent of its role in facilitating DNA methy-
lation.
HELLS is not a core HR factor but facilitates homologous
recombination within heterochromatin
We observed fewer IR-induced Rad51 foci, but not ablation
of foci formation in cells depleted of HELLS. This led us to
consider whether there may be a subset of breaks that re-
quire HELLS for their efficient repair via HR. We utilized
the DR-GFP assay to study the effect of HELLS on HR
activity (53). In this system, a reporter cassette compris-
ing GFP interrupted by an I-SceI endonuclease site and a
downstream fragment of GFP has been integrated into the
genome of U2OS cells (54). Induction of I-SceI results in
HR repair of the direct repeats to generate functional GFP
(Figure 3A). Depletion of the core HR factor BRCA1, re-
sulted in fewer GFP-positive cells relative to control cells.
However, cells depleted of HELLS did not show a signifi-
cant HR defect using this reporter and downregulation of
both HELLS and BRCA1 did not further reduce the num-
ber of GFP-positive cells compared to depletion of BRCA1
alone (Figure 3A). This indicates that HELLS is not an es-
sential HR factor. However, if HELLS functions to pro-
mote HR within a specific genomic context such as hete-
rochromatin, location of the DR-GFP reporter construct
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Figure 2. HELLS depletion results in defects in the homologous recombination pathway of DSBR. (A) Immunofluorescence images of endogenous HELLS
expression and localization. (B) Representative immunofluorescent images of Rad51 foci in G2 cells following IR in 1Br-hTert cells transfected with the
indicated siRNA. (C) Quantification of IR-induced Rad51 foci in G2 nuclei of 1BR-hTert cells transfected with indicated siRNA. (D) Quantification of
IR-induced Rad51 foci in G2 nuclei of U2OS cells transfected with indicated siRNA. (E) Quantification of sister chromatid exchange events in HeLa
cells transfected with the indicated siRNA and analysed 12 h after 3 Gy IR. Frequency of exchange events was calculated per 100 chromosomes from a
minimum of 35 spreads from two independent experiments and analysed by an unpaired t-test. (F) Viability curves from clonogenic assays of 1Br-hTert cells
transfected with the indicated siRNA following exposure to olaparib. **** indicates a P-value of <0.0001, ** indicates P-value of <0.01 and ns indicates
not significant by unpaired two-tailed t-test analysis. Data in panels C, D and F are represented as mean + SEM from three independent experiments.
pected to result in a defect in this assay. Consistent with this,
cells defective in Artemis do not display a defect in the DR-
GFP assay and loss of ATM activity results in only a modest
decrease in activity (4); both ATM and Artemis have been
implicated in HR repair of breaks within heterochromatin.
As HELLS is a member of the Snf2-like family of chro-
matin remodelling enzymes, we investigated whether re-
laxation of chromatin structure could overcome the re-
quirement for HELLS in HR repair of IR-induced breaks
during G2. We treated cells transfected with control or
HELLS siRNA with chloroquine, to yield more open chro-
matin (55,56) and analysed persistence of  -H2AX foci and
RAD51 foci formation after IR in G2 (Figure 3B, C, Sup-
plementary Figure S3A–C). As shown above, downregula-
tion of HELLS resulted in elevated numbers of  -H2AX
foci 24 h following irradiation compared to control cells
(Figure 3B and Supplementary Figure S3A). These persis-
tent foci were not present in HELLS-depleted cells treated
with chloroquine, indicating that relaxation of chromatin
structure overcomes the requirement of HELLS for repair
of a subset of breaks. Similarly, the defect in RAD51 foci
formation on HELLS downregulation was rescued by in-
cubation of HELLS-depleted cells with chloroquine (Fig-
ure 3C and Supplementary Figure S3B), consistent with
HELLS being non-essential for HR but facilitating HR in
compact chromatin.
Breaks within densely compact heterochromatin require
local opening of chromatin structure to be repaired effi-
ciently. During G1, the CHD3 and SMARCA5 chromatin
remodellers contribute to repair within heterochromatin
(18,19,57). During G2, slow-clearing  -H2AX foci are pro-
posed to represent breaks within heterochromatic regions of
the genome, repaired by HR in an ATM-dependent manner
(4,11). Persistent  -H2AX foci occur in G2 cells depleted
of Artemis, RAD51 and BRCA2 or when phosphorylation
of the heterochromatin protein KRAB associated protein 1
(KAP-1) is prevented by downregulation of ATM or mu-
tation of the KAP-1 phosphorylation site (11,58). Impor-
tantly, depletion of KAP-1 rescues the DSB repair defect of
G2 cells downregulated for BRCA2 or ATM (4,59). Given
the association of slow-repairing breaks with HR within
heterochromatin, the role of mouse LSH in DNA methyla-
tion at heterochromatin (37,50,60) and the requirement for
chromatin remodelling enzymes for repair of heterochro-
matic DSBs during G1, we hypothesized HELLS may con-
tribute to repair of breaks within heterochromatin during
G2.
Cells treated with ATMi display persistence of IR-
induced breaks in G2 which is alleviated by downregulation
of the heterochromatin protein KAP-1 (4). We find that de-
pletion of HELLS alone is sufficient to cause persistence of
 -H2AX foci, even in the presence of active ATM. We com-
pared the effect of HELLS-depletion to the effect of ATM
inhibition on  -H2AX foci numbers following IR in G2.
HELLS-depleted cells and those treated with ATMi pos-
sessed similar numbers of unrepaired breaks 6 hours after
IR exposure (Figure 3D and Supplementary Figure S3D).
In addition, combining transfection of HELLS siRNA with
ATM inhibition did not result in an additive defect, con-
sistent with HELLS and ATM acting epistatically to affect
HR repair in heterochromatic regions of the genome in G2.
Immunofluorescent imaging of endogenous HELLS re-
vealed small, bright, nuclear punctae, as well as background
pan-nuclear staining in S/G2 cells (Figure 2A). We exam-
ined the localization of  -H2AX relative to HELLS punc-
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Figure 3. HELLS is not essential for HR but facilitates homologous recombination within heterochromatin. (A) HR efficiency assay in U2OS DR-GFP
cells transfected with I-SceI expression plasmid and the indicated siRNA. GFP positive cells represent HR repair using a downstream wt-GFP sequence
as a donor template and were analysed by FACS. (B) Quantification of rescue of  -H2AX foci clearance 24 h after 3 Gy irradiation in 1BR-hTert cells
transfected with indicated siRNA by the addition of 40 g/ml chloroquine 2 h prior to irradiation. (C) Quantification of rescue of Rad51 foci 2 h after 3
Gy irradiation in 1BR-hTert cells transfected with indicated siRNA by the addition of 40 g/ml chloroquine 2 h prior to irradiation. (D) Quantification
of clearance of  -H2AX foci by following 3 Gy irradiation in 1BR-hTert cells treated with indicated siRNA in the absence or presence of 10 M ATMi,
which was added 1 h prior to irradiation. (E) Representative immunofluorescent images of HELLS and  -H2AX foci colocalization. (F) Quantification
of colocalization of  -H2AX with HELLS at 2 and 24 h following irradiation with 3 Gy IR. Data represent the fraction of  -H2AX positive pixels that
overlap with HELLS-positive pixels for 383 nuclei at 2h and 242 nuclei at 24 h from three independent experiments, with median value and interquartile
range shown. The average number of  -H2AX remaining from data in Figure 1F is indicated. (G) Quantification of rescue of clearance of  -H2AX
foci following 3 Gy irradiation by KAP-1 depletion in 1BR-hTert cells. Data for siCon and siHELLS alone is the same as that shown in Figure 1F and
Supplementary Figure S1E. (H) Quantification of rescue of Rad51 foci formation 2 h following 3 Gy irradiation by KAP-1 depletion in 1BR-hTert cells
treated with indicated siRNA. **** indicates a P-value of <0.0001, ** indicates P-value of <0.01 and ns indicates not significant by unpaired two-tailed
t-test analysis. Data in panels A–D, G and H are shown as the mean + SEM from three independent experiments.
HELLS did not form visible IR-induced foci and 2 h af-
ter irradiation  -H2AX foci were stochastically distributed
within the nucleus with no significant colocalization of
HELLS and  -H2AX i.e. some breaks overlapped with
HELLS punctae whilst others did not (Figure 3E, F and
Supplementary Figure S3E). However, 24 hours after ir-
radiation, when many of the  -H2AX foci had been re-
solved due to repair, those  -H2AX foci that remained
showed increased association with HELLS punctae. Anal-
ysis of the fraction of  -H2AX pixels that overlapped with
HELLS staining confirmed greater colocalization of breaks
with HELLS 24 hours after irradiation compared to after 2
hours (Figure 3F). Irradiation had no effect on the number
or appearance of HELLS punctae (Supplementary Figure
S3F). This suggests that slow-repairing breaks, proposed to
be associated with heterochromatin, have a greater tendency
to overlap with sites enriched in HELLS than faster repair-
ing euchromatic breaks.
Chloroquine relaxes chromatin globally; to specifically
examine whether HELLS affects repair within heterochro-
matin, heterochromatin structure was disrupted by deple-
tion of KAP-1. Downregulation of KAP-1 alone did not
alter the number of  -H2AX foci relative to controls and
did not affect the punctate nuclear localization of HELLS
(Figure 3G, Supplementary Figure S3G and H). Strikingly,
the elevated numbers of  -H2AX foci at 6 and 24 h post-
irradiation in HELLS-depleted cells were alleviated by si-
multaneous depletion of KAP-1, i.e. persistent breaks in
HELLS-deficient cells can be repaired more rapidly if KAP-
1 is downregulated. To test whether the HELLS-dependent
defect in the HR pathway is also rescued by disruption of
heterochromatin, IR-induced RAD51 foci formation was
analysed after KAP-1 depletion (Figure 3H and Supple-
mentary Figure S3I). KAP-1 depletion was able to over-
come the reduction in number of RAD51 foci in cells in
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timeframe of our assays, depletion of HELLS did not result
in a significant change in the global levels of the heterochro-
matin mark H3K9me3 (Supplementary Figure S3J). These
data show that repair can occur in a HELLS-independent
manner upon depletion of KAP-1 and are consistent with
a function for HELLS in relieving or removing a barrier to
HR that is posed by heterochromatin.
Phosphorylation of KAP-1 S824 is ATM-dependent and
required for initial chromatin relaxation and efficient re-
pair within heterochromatin during G1 (58,61,62). In G2
cells, pATM is subsequently lost from break sites during re-
section to favour HR (59). We observed that levels of IR-
induced S824 phosphorylation of KAP-1 were not altered
by depletion of HELLS, either by western blot or when vi-
sualized by IF (Supplementary Figure S3K and L). There-
fore, global phosphorylation of KAP-1 alone is insufficient
to permit efficient repair within heterochromatin; HELLS
may either act downstream or perform a distinct function
to KAP-1 phosphorylation.
Together our data are consistent with a model where
HELLS promotes repair within heterochromatin via HR
by overcoming a barrier posed by chromatin structure in
these regions of the genome and consequently depletion of
HELLS results in repair of these breaks being impeded. We
do not exclude the possibility that HELLS may additionally
contribute to repair within euchromatic regions, although
not as an essential HR factor.
HELLS facilitates end-resection
Having established that HELLS contributes to repair within
heterochromatin, we began to dissect which step of HR
is impacted by HELLS downregulation. Chromatin is a
known barrier to the first step of HR, end-resection (63,64).
The 3′-ssDNA tails that are generated are coated with RPA,
which is subsequently replaced by RAD51. As such, the re-
duction in IR-induced RAD51 foci formation in HELLS-
depleted cells could either be the result of a defect in RAD51
loading or further upstream in the HR pathway. Firstly, we
studied accumulation of the ssDNA binding protein, RPA,
into IR-induced foci in G2 in HELLS-depleted cells (Fig-
ure 4A). Analysis of both the average number of RPA foci
per G2 nucleus and the percentage of G2 nuclei with >20
foci revealed a defect in RPA foci formation in HELLS-
depleted cells after irradiation (Figure 4B, C and Supple-
mentary Figure S4A). Decreased RPA foci formation sug-
gests a defect ssDNA formation in HELLS-depleted cells.
ssDNA can be monitored more directly using an assay in-
volving BrdU incorporation into DNA prior to irradiation.
Following DSB formation, resection results in regions of ss-
DNA that can be visualized using an anti-BrdU antibody
under non-denaturing conditions. We performed analysis 1
hour after irradiation, when maximal numbers of foci are
observed, using a dose that results in a quantifiable number
of foci; these conditions have been extensively used to study
effects on resection including for another chromatin remod-
elling protein, SMARCAD1 (65,66) (Supplementary Fig-
ure S4B). As anticipated, given its role in initiation of end-
resection, depletion of CtIP resulted in formation of fewer
BrdU foci than in control cells (Figure 4D). Consistent with
the defect in RPA foci formation, cells depleted of HELLS
Figure 4. HELLS facilitates end-resection. (A) Representative im-
munofluorescent images of RPA foci in CENPF-positive G2 nuclei fol-
lowing 3 Gy IR. (B) Quantification of average number of IR-induced RPA
foci per G2 nucleus in 1BR-hTert cells transfected with indicated siRNA.
(C) Quantification of % of G2 nuclei containing greater than 20 RPA foci
in 1BR-hTert cells transfected with siCon or siHELLS. (D) Quantifica-
tion of number of BrdU foci per nucleus 1 h after 10 Gy, visualized under
non-denaturing conditions and therefore representing regions of ssDNA,
in U2OS cells transfected with indicated siRNA. (E) Quantification of res-
cue of RPA foci 2 h following 3 Gy irradiation in 1BR-hTert cells treated
with indicated siRNA by the addition of 40 g/ml chloroquine 2 h prior to
irradiation. (F) Quantification of the effect of the transcription inhibitor,
DRB on RPA foci formation 2 h following 3 Gy irradiation. 100 M DRB
was added 1 h prior to irradiation to 1BR-hTert cells treated with indicated
siRNA. **** indicates a P-value of <0.0001, and ns indicates not signifi-
cant by unpaired two-tailed t-test analysis. Data in panels B–E are shown
as the mean + SEM from three independent experiments.
also contained fewer ssDNA foci. The decrease in number
of BrdU foci following HELLS downregulation is not as
pronounced as the defect in CtIP-depleted cells, consistent
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Using IR-induced RPA foci number as a marker of ss-
DNA formation, we examined whether relaxation of chro-
matin structure could also rescue the end-resection defect
of HELLS-depleted cells. Addition of chloroquine restored
the number of IR-induced RPA foci in HELLS-depleted
cells to the levels observed in cells transfected with control
siRNA (Figure 4E and Supplementary Figure S4C).
Recent studies have reported that DSBs in transcription-
ally active regions can also be repaired by HR via a process
termed TA-HRR (transcription-associated homologous re-
combination repair) (67,68). During G2, approximately one
third of DSBs are repaired by TA-HRR, with the other two
thirds of DSBs (including those associated with heterochro-
matin) being repaired in a manner independent of transcrip-
tion. Addition of a transcription inhibitor, DRB, to cells
depleted of HELLS resulted in a further reduction in the
number of RPA foci in G2 nuclei. This indicates that the
HR defect in HELLS-depleted cells occurs largely at a dis-
tinct class of breaks that those in transcriptionally-active,
open regions of chromatin, which are repaired by TA-HRR
(Figure 4F and Supplementary Figure S4D). Importantly,
these data are in agreement with HELLS not being impor-
tant for HR repair of all DSBs, but are consistent with a role
in HR repair within heterochromatin. In summary, we find
that HELLS facilitates end-resection, the initial step of the
HR pathway, within heterochromatin.
During G2, 53BP1 both negatively and positively influ-
ences HR. In G2 cells, a BRCA1-dependent mechanism
alleviates the inhibitory effect of 53BP1 on resection by
promoting 53BP1 dephosphorylation, however 53BP1 also
contributes to HR via relaxation of densely packed hete-
rochromatin (69). We examined epistasis of HELLS and
53BP1 in ssDNA BrdU foci and RPA foci accumulation.
In both assays, 53BP1 depletion failed to rescue the end-
resection defects observed in HELLS depleted cells (Sup-
plementary Figure S4E and F). This indicates that the
mechanism by which HELLS facilitates end-resection is not
through removing the inhibitory effect of 53BP1. Indeed,
a small additive defect was observed when HELLS and
53BP1 were simultaneously downregulated, indicating that
they do not exclusively function in the same pathway.
There is precedent for involvement of ATP-dependent
chromatin remodellers promoting end-resection during
DSB repair. Phosphorylated SMARCAD1 is recruited to
breaks where it acts to facilitate long-range end-resection
by repositioning 53BP1 (unlike HELLS-depleted cells, the
resection defect in SMARCAD1-depleted cells is rescued by
downregulation of 53BP1) (57,64). We examined the effect
of SMARCAD1 and HELLS depletion on ssDNA accu-
mulation by analysis of RPA foci accumulation following
IR (Supplementary Figure S4G). Downregulation of either
remodeller resulted in reduced numbers of RPA foci, sug-
gesting that expression of both SMARCAD1 and HELLS
is necessary for optimal HR efficiency and that they may
be unable to fully compensate for each other. This could
be an indication that differing chromatin remodelling ac-
tivities are required at different steps in DSBR and in dif-
ferent chromatin contexts. Co-depletion of SMARCAD1
and HELLS resulted in a similar level of RPA foci accu-
mulation, or a subtly larger defect than that observed upon
downregulation of SMARCAD1 alone.
The HELLS protein interacts with CtIP and contributes to
its accumulation at IR-induced breaks
Chromatin structure may affect recruitment and retention
of the end-resection machinery and/or influence the pro-
cessivity or efficiency of nuclease activity. To examine if ac-
cumulation of proteins involved in the initial steps of end-
resection was HELLS-dependent, we introduced a GFP-
tagged version of CtIP to U2OS cells and analysed its
accumulation at IRIF. Four hours after exposure to IR,
cells depleted of HELLS displayed fewer nuclear GFP-
CtIP foci than control cells (Figure 5A, B and Supple-
mentary Figure S5A). Therefore, HELLS appears to en-
able either recruitment or retention of the CtIP protein at
breaks, in accordance with a function in promoting initia-
tion of end-resection. There was not a reciprocal effect on
localization, as the punctate nuclear localization of HELLS
was not grossly altered by depletion of CtIP (Figure 5C);
while HELLS impacts accumulation of CtIP, localization
of HELLS is independent of CtIP.
Levels of CtIP protein, evaluated by western blotting of
whole cell extracts, are not decreased (in fact they are mod-
estly elevated) upon depletion of HELLS, indicating that
the defect in formation of IR-induced CtIP foci is not the
result of reduced CtIP expression (Figure 5D). Nor is there
a significant effect of CtIP depletion on HELLS levels or
significant changes in HELLS expression following irradia-
tion.
One mechanism by which HELLS could promote ac-
cumulation of CtIP at IR-induced foci is through interac-
tion of HELLS and CtIP proteins. We introduced to U2OS
cells a plasmid expressing CtIP-GFP, either by itself or
along with a plasmid expressing Myc-HELLS. Immunopre-
cipitation using an anti-myc antibody from cells express-
ing myc-tagged HELLS, resulted in the coimmunoprecip-
itation of CtIP-GFP (Figure 5E). Immunoprecipitation of
CtIP-GFP with Myc-HELLS was not stimulated by irradia-
tion (Figure 5F). An interaction between HELLS and CtIP
proteins was confirmed using recombinant purified pro-
teins. CtIP and His-tagged human HELLS were expressed
and purified from insect cells (Supplementary Figure S5B)
and His-HELLS immobilized on cobalt beads was able to
pull-down CtIP (Figure 5G). These data demonstrate a di-
rect protein-protein interaction between HELLS and CtIP,
which may contribute to the HELLS-dependent accumu-
lation of CtIP at IR-induced breaks during G2 and subse-
quent end-resection.
CtIP foci accumulation after IR was rescued by expres-
sion of an siRNA resistant version of HELLS, wt Myc-
HELLS, in cells in which endogenous HELLS had been
depleted (Figure 5H and Supplementary Figure S5C). This
confirms that HELLS function is required for CtIP local-
ization following IR. Introduction of an siRNA-resistant
ATP-binding site mutant of HELLS did not result in rescue
of CtIP IRIF foci formation (Figure 5H). HELLS K254R
retains the ability to associate with the chromatin fraction
(Supplementary Figure S5D) and recombinant HELLS
K254R protein was still able to bind to CtIP (Figure 5I),
suggesting that the ability of HELLS to remodel chromatin
structure, as well as bind CtIP contributes to full stimula-
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Figure 5. HELLS interacts with CtIP and contributes to its accumulation at IR-induced breaks. (A) Representative immunofluorescent images of CtIP-GFP
foci 4h following 3 Gy IR in U2OS cells transfected with CtIP-GFP plasmid and the indicated siRNA. (B) Quantification of average number of IR-induced
CtIP-GFP foci in U2OS cells transfected with CtIP-GFP plasmid and indicated siRNA. (C) Representative immunofluorescent images showing that the
punctate localization of HELLS in 1BR-hTert nuclei is not disrupted by depletion of CtIP. (D) Western blot analysis of levels of CtIP and HELLS in whole
cell extracts prepared from U2OS cells transfected with the indicated siRNA. Alpha tubulin was used as a loading control. (E) Immunoprecipitation of
CtIP with Myc-HELLS from nuclear extracts of U2OS cells transfected with indicated plasmids, analysed by western blotting. (F) Immunoprecipitation
of CtIP with Myc-HELLS from nuclear extracts of U2OS cells transfected with indicated plasmids 1 h following 3 Gy IR, analysed by western blotting.
(G) Western blot analysis of pull-down assay using nickel beads and purified recombinant His-HELLS and CtIP proteins. (H) Quantification of rescue of
average number of IR-induced CtIP-GFP foci in U2OS cells transfected with CtIP-GFP expressing plasmid, HELLS siRNA and constructs expressing
siRNA-resistant wt or ATPase mutant HELLS. For panels B and I, foci were counted blind and data represent the mean + SEM from three independent
experiments. **** indicates a P-value of <0.0001, and ns indicates not significant by unpaired two-tailed t-test analysis. (I) Western blot analysis of pull-
down of CtIP by wt and K254R mutant HELLS proteins using anti-His and protein G Dynabeads. (J) Cartoon model of the role of HELLS at a DSB
within heterochromatin. HELLS activity along with ATM-dependent phosphorylation of KAP-1 results in changes to the structure of heterochromatin
that facilitate accumulation of CtIP. CtIP recruitment or retention is promoted by interaction with HELLS to help initiate end-resection and HR.
DISCUSSION
This work uncovers a role for chromatin remodelling ac-
tivity in DSBR repair in G2 and provides details of the
function of HELLS in maintenance of genome stability.
We find that the human HELLS chromatin remodelling en-
zyme, is required for efficient repair of two-ended DSBs
within heterochromatin in G2. Repair of these heterochro-
matic breaks by HR is impaired and end-resection defec-
tive when HELLS is downregulated, with the ATP bind-
ing site of HELLS required for its function in DSBR.
We demonstrate that HELLS facilitates accumulation of
CtIP at IR-induced breaks and identify an interaction be-
tween HELLS and CtIP proteins. Compact heterochro-
matin poses a particular challenge to DNA repair pro-
cesses and our findings highlight the importance of spe-
cific chromatin remodelling activities during repair in dif-
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The structure of heterochromatin acts as a barrier to re-
cruitment and activity of DSB repair proteins. We propose
that HELLS establishes a chromatin structure that permits
recruitment, retention and activity of the end-resection ma-
chinery at breaks within heterochromatin. Given the re-
quirement for an intact ATPase motif within HELLS, and
that disruption of heterochromatin structure by depletion
of KAP-1 rescues repair defects that occur upon HELLS
downregulation, this likely involves decondensation or re-
laxation of heterochromatin, stimulated by chromatin re-
modelling by HELLS. We propose that HELLS facilitates
end-resection through a combination of chromatin remod-
elling to generate a chromatin environment suitable for re-
cruitment of the end-resection machinery, and interaction
of HELLS and CtIP to assist recruitment or retention of re-
section proteins (Figure 5J). Given that depletion of KAP-
1 rescues the resection defect of HELLS-depleted cells,
and that persistent breaks display a tendency to colocalize
with HELLS, we favour a model where the contribution of
HELLS to DSB repair is direct, rather than due to misreg-
ulation of transcription. Consistent with this, transcription
of known DNA repair genes is not significantly changed
and only 0.4% of transcripts are altered in LSH –/– MEFs
(24).
We did not detect a change in the amount of chromatin-
bound HELLS after IR and the pattern of HELLS local-
ization by immunofluorescence was indistinguishable from
that of undamaged cells. Therefore, a fraction of HELLS
may be constitutively present at heterochromatin and either
its remodelling activity stimulated by break formation or
post-translational modification of either HELLS or CtIP
could occur to regulate interaction with the end-resection
machinery. The question of how the HELLS-CtIP interac-
tion is regulated will be of future interest.
We find that HELLS is not an essential global HR factor;
HELLS-deficient cells did not show a significant loss of HR
activity in a frequently utilized direct repeat reporter assay,
disruption of chromatin structure can rescue RAD51 and
RPA foci formation in cells downregulated in HELLS, and
olaparib sensitivity is more pronounced following depletion
of the core HR protein BRCA1 than HELLS. However,
consistent with a function in enabling HR, HELLS expres-
sion is highest in proliferating tissues, active in recombina-
tion such as testes and thymus. We uncovered impaired ac-
cumulation of HR pathway proteins in HELLS downreg-
ulated cells, but also defects in some readouts of HR re-
pair. In agreement with the PARPi sensitivity that we ob-
served, the HELLS gene was identified in a genome-wide
shRNA screen for olaparib sensitivity, and as part of a gene
signature associated with response to PARP inhibition in
a panel of triple-negative breast cancer cell lines (70,71).
Many lesions that arise due to PARP inhibition are repaired
by HR during S-phase, but some may progress to G2. Unre-
solved breaks may be repackaged into heterochromatin and
could give rise to the modest PARPi sensitivity observed in
HELLS-depleted cells. PARP-dependent Alt-NHEJ can act
at some DSBs in the absence of functional HR, such as in
BRCA2-disrupted cells and a similar mechanism may occur
in cells depleted of HELLS resulting in increased sensitivity
siHELLS cells to PARPi. We do not discount the possibil-
ity that HELLS may also contribute to repair of other sub-
classes of breaks or repair pathways and acknowledge that
additional functions of HELLS may influence the sensitiv-
ity to PARP inhibition. Rather that acting as a core HR pro-
tein, we suggest that HELLS facilitates recombination at a
subset of DSBs, including those located within heterochro-
matin.
In support of a function at heterochromatin, LSH colo-
calizes with chromocenters, HP1 and late replication foci
(38) and was also found to ChIP (although not exclu-
sively) to repetitive heterochromatin-enriched regions of the
genome (27). Notably, HELLS mutations have been iden-
tified in ICF syndrome, which is characterized by genomic
rearrangements in heterochromatic pericentromeric regions
(32). The loss of functional HELLS and efficient HR re-
pair of breaks within heterochromatin may contribute to
the pericentric instability observed in cells from these pa-
tients
Phosphorylation of the KAP-1 heterochromatin protein
is necessary for efficient repair of heterochromatin breaks
in G2. As both HELLS and KAP-1 phosphorylation are
epistatic with ATM, HELLS could act downstream of
KAP-1 phosphorylation (KAP-1 phosphorylation still oc-
curs on HELLS downregulation). Alternatively, the effect
of HELLS on heterochromatin structure during DSBR may
be distinct from remodelling events that occur upon KAP-1
phosphorylation. We cannot exclude that HELLS may af-
fect a second, downstream step of repair within heterochro-
matin, in addition to recruitment of the resection machin-
ery. For example, HELLS could contribute to efficient pro-
gression of resection, recruitment of HC factors that occurs
following initial local chromatin decompaction or to relo-
calization of breaks within the nucleus (59,72,73).
In contrast to cells depleted of HELLS or BRCA2 or
treated with ATMi, cells depleted of CtIP do not show
persistent G2  -H2AX foci following IR (42,59). In CtIP-
depleted cells, resection is not initiated and therefore breaks
within heterochromatin that would normally be repaired by
HR can be redirected into an end-joining pathway. Despite
displaying a defect in CtIP accumulation in response to IR,
HELLS-depleted cells possessed elevated numbers of unre-
paired breaks at later time points after irradiation, suggest-
ing that an alternative repair pathway is also unable to func-
tion efficiently; co-depletion of HELLS and CtIP resulted
in the same persistence of  -H2AX foci as depletion of
HELLS alone (Supplementary Figure S5E and S5F). This
indicates that the chromatin remodelling activity of HELLS
is required not only for the preferred HR pathway, but also
for factors in the compensating end-joining pathway to ac-
cess heterochromatin during G2. In this study we have ex-
amined HR repair of IR-induced breaks in G2, however
breaks within heterochromatin are also repaired with slow
kinetics in G1 (although in this instance they are repaired
by NHEJ). Recently, resection-dependent c-NHEJ involv-
ing CtIP has been shown to occur in G1 (74) and it will be
of interest to examine if HELLS additionally impacts CtIP-
dependent NHEJ within heterochromatin during G0/G1 or
compensatory end-joining when resection is inhibited dur-
ing G2.
We observed elevated spontaneous H2AX phosphory-
lation and persistence of IR-induced  -H2AX foci in
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lasts. It has previously been reported that mammalian
HELLS promotes efficient phosphorylation of H2AX (24).
There are several possible explanations for this apparent
discrepancy including cell cycle effects, our use of lower,
non-lethal doses of radiation, x-rays vs  -gays and method
of HELLS-depletion. There may also be differences be-
tween murine and human DNA damage responses within
heterochromatin. Consistent with our data, spontaneous  -
H2AX foci have recently been observed in an undamaged
HEK293 HELLS KO cell line (75).
HELLS/LSH have been most extensively studied for
their role in de novo DNA methylation. We did not ob-
serve HR pathway defects upon depletion of DNMT3b or
DNMT1 DNA methyltransferases and in agreement with
this, ICF patient cells carrying mutant DNMT3b display
unaltered DSBR repair (76). Nonetheless, DNA methyla-
tion may still contribute to the overall decreased genome
stability in cells lacking functional HELLS; both defec-
tive DSBR and hypomethylation and misfunction of cen-
tromeres during chromosome segregation could result in
increased incidence of micronuclei. This may be relevant
to ICF syndrome patients with HELLS mutations, given
that hypomethylation of repeat sequences is observed at a
subset of chromosomes and the most frequently observed
mutations in ICF syndrome are within DNMT3b (77,78).
HELLS has been associated with hypomethylation of spe-
cific repeat elements in some colorectal tumours (49). How-
ever, DNA methylation does not occur in budding yeast and
consequently it seems likely to be the function in DNA re-
pair that is conserved in the yeast homolog, Irc5.
Many chromatin remodelling enzymes function in sev-
eral cellular processes, including DNA repair, transcription,
chromosome segregation and replication. These pleiotropic
effects are expected to contribute to the prevalence of mu-
tations or misregulation of chromatin remodelling enzyme
subunits in cancer. HELLS may perform multiple roles
within the cell, such that HELLS downregulation or muta-
tion may increase genetic instability and additional effects
on DNA methylation and transcription could contribute to
tumourigenesis. By elucidating a mechanism through which
HELLS impacts DSB repair, this study raises the potential
for targeted therapeutic treatment such as PARP inhibitors,
if tumours could be stratified by their HELLS status. No-
tably, HELLS overexpression is associated with progres-
sion of squamous cell, oropharyngeal and prostate cancers,
with high HELLS levels also found in bladder, retinal, lung
and ovarian tumours and HELLS expression a potential
biomarker for melanoma metastasis (27,29–31). It will be of
interest to determine whether HELLS upregulation also af-
fects genome stability or if its impact on cancer progression
is due to another mechanism such as transcriptional mis-
regulation of genes that drive proliferation. In either case, it
appears that there is an optimal level of HELLS activity for
preventing tumourigenesis.
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